160 related articles for article (PubMed ID: 33482350)
41. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
43. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.
Fillies T; Werkmeister R; van Diest PJ; Brandt B; Joos U; Buerger H
BMC Cancer; 2005 Jul; 5():84. PubMed ID: 16035955
[TBL] [Abstract][Full Text] [Related]
44. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
45. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
[TBL] [Abstract][Full Text] [Related]
46. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
47. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
48. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
[TBL] [Abstract][Full Text] [Related]
49. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
Jögi A; Ehinger A; Hartman L; Alkner S
PLoS One; 2019; 14(12):e0226150. PubMed ID: 31821370
[TBL] [Abstract][Full Text] [Related]
50. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
51. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
Bos R; van Diest PJ; van der Groep P; Shvarts A; Greijer AE; van der Wall E
Breast Cancer Res; 2004; 6(4):R450-9. PubMed ID: 15217513
[TBL] [Abstract][Full Text] [Related]
52. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
[TBL] [Abstract][Full Text] [Related]
53. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
54. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
[TBL] [Abstract][Full Text] [Related]
55. Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis.
Lodewijk L; van Diest P; van der Groep P; Ter Hoeve N; Schepers A; Morreau J; Bonenkamp J; van Engen-van Grunsven A; Kruijff S; van Hemel B; Links T; Nieveen van Dijkum E; van Eeden S; Valk G; Borel Rinkes I; Vriens M
Oncotarget; 2017 Apr; 8(17):28650-28659. PubMed ID: 28404916
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
[TBL] [Abstract][Full Text] [Related]
57. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
58. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis.
Cao S; Yang S; Wu C; Wang Y; Jiang J; Lu Z
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):598-603. PubMed ID: 24835771
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
60. Comparative expression analysis of hypoxia-inducible factor-alpha and its natural occurring antisense in breast cancer tissues and adjacent noncancerous tissues.
Tasharrofi B; Soudyab M; Nikpayam E; Iranpour M; Mirfakhraie R; Sarrafzadeh S; Geranpayeh L; Azargashb E; Sayad A; Ghafouri-Fard S
Cell Biochem Funct; 2016 Dec; 34(8):572-578. PubMed ID: 27862063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
